Published in Radiat Res on July 01, 1989
Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med (1989) 2.69
Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest (1989) 1.87
Interleukin 1 is a radioprotector. J Immunol (1986) 1.80
Specific suppression of delayed hypersensitivity: the possible presence of a suppressor B cell in the regulation of delayed hypersensitivity. J Immunol (1974) 1.73
Induction of colony stimulating factor in vivo by recombinant interleukin 1 alpha and recombinant tumor necrosis factor alpha 1. J Immunol (1987) 1.50
Recombinant interleukin-1 alpha and recombinant tumor necrosis factor alpha synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes. Infect Immun (1988) 1.48
Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock. J Clin Invest (1986) 1.34
Interaction of recombinant IL-1 and recombinant tumor necrosis factor in the induction of mouse acute phase proteins. J Immunol (1988) 1.25
Roles of interleukin-1 and tumor necrosis factor in lipopolysaccharide-induced hypoglycemia. Infect Immun (1991) 1.23
Role of cytokines (interleukin 1, tumor necrosis factor, and transforming growth factor beta) in natural and lipopolysaccharide-enhanced radioresistance. J Exp Med (1991) 1.23
Effect of liposome-mediated macrophage depletion on LPS-induced cytokine gene expression and radioprotection. J Immunol (1995) 1.18
T and B lymphocytes in the regulation of delayed hypersensitivity. J Immunol (1976) 1.18
Resistance and susceptibility to infection in inbred murine strains. I. Variations in the response to thymic hormones in mice infected with Candida albicans. Cell Immunol (1983) 1.16
Antibodies chaperone circulating IL-6. Paradoxical effects of anti-IL-6 "neutralizing" antibodies in vivo. J Immunol (1993) 1.15
In vivo release of lymphokines in different strains of mice. Cell Immunol (1980) 1.12
Recovery of aerobic and anaerobic bacteria from irradiated mice. Infect Immun (1984) 1.12
Interleukin-1 and interleukin-6 act synergistically to stimulate the release of adrenocorticotropic hormone in vivo. Lymphokine Cytokine Res (1991) 1.09
Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology (1993) 1.09
The role of interleukin-6 in lipopolysaccharide-induced weight loss, hypoglycemia and fibrinogen production, in vivo. Cytokine (1993) 1.08
A possible relationship between delayed hypersensitivity and cell-mediated immunity. Am Rev Respir Dis (1975) 1.05
Specific depression of delayed hypersensitivity to purified proteins, with relation to production of circulating antibody. Cell Immunol (1973) 1.04
Administration of interleukin-6 stimulates multilineage hematopoiesis and accelerates recovery from radiation-induced hematopoietic depression. Blood (1991) 1.04
An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance. Infect Immun (1991) 1.03
Cardiovascular performance with E. coli challenges in a canine model of human sepsis. Am J Physiol (1988) 1.02
Postirradiation treatment with granulocyte colony-stimulating factor and preirradiation WR-2721 administration synergize to enhance hemopoietic reconstitution and increase survival. Int J Radiat Oncol Biol Phys (1992) 1.02
Effect of antimicrobial therapy on bowel flora and bacterial infection in irradiated mice. Int J Radiat Biol Relat Stud Phys Chem Med (1988) 1.01
Recombinant human megakaryocyte growth and development factor stimulates thrombocytopoiesis in normal nonhuman primates. Blood (1995) 1.01
Sublethal gamma irradiation increases IL-1alpha, IL-6, and TNF-alpha mRNA levels in murine hematopoietic tissues. J Interferon Cytokine Res (1997) 1.01
Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity. J Natl Cancer Inst (1975) 1.01
Therapeutic use of recombinant human G-CSF (rhG-CSF) in a canine model of sublethal and lethal whole-body irradiation. Int J Radiat Biol (1990) 1.01
Enhanced clearance of a multiple antibiotic resistant Staphylococcus aureus in rats treated with PGG-glucan is associated with increased leukocyte counts and increased neutrophil oxidative burst activity. Int J Immunopharmacol (1998) 1.00
Adjuvants in the induction of suppressor cells. Infect Immun (1979) 0.99
Antibiotics versus cardiovascular support in a canine model of human septic shock. Am J Physiol (1990) 0.99
Inhibition of prostaglandin synthesis restores normal hemodynamics in canine hyperdynamic sepsis. Ann Surg (1984) 0.98
The in vivo effects of interleukin 1. I. Bone marrow cells are induced to cycle after administration of interleukin 1. J Immunol (1987) 0.98
Bone marrow transplantation in miniature swine. I. Development of the model. Transplantation (1988) 0.96
Cellular immunity in vitro: migration inhibition and phagocytosis. Infect Immun (1971) 0.96
TNF but not IL-1 in dogs causes lethal lung injury and multiple organ dysfunction similar to human sepsis. J Appl Physiol (1985) (1991) 0.94
Resistance and susceptibility to infection in inbred murine strains. II. Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokines in vivo. Cell Immunol (1983) 0.94
Survival enhancement and hemopoietic regeneration following radiation exposure: therapeutic approach using glucan and granulocyte colony-stimulating factor. Exp Hematol (1990) 0.94
Hemopoietic effects of intravenous soluble glucan administration. J Immunopharmacol (1986) 0.94
The detection of in vitro monocyte-macrophage colony-forming cells in mouse thymus and lymph nodes. J Cell Physiol (1977) 0.93
Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood (1999) 0.93
Glucan: mechanisms involved in its "radioprotective" effect. J Leukoc Biol (1987) 0.93
The effect of recombinant GM-CSF on the recovery of monkeys transplanted with autologous bone marrow. Blood (1987) 0.93
Interleukin-1 enhances survival of lethally irradiated mice treated with allogeneic bone marrow cells. Blood (1989) 0.92
Therapeutic administration of recombinant human granulocyte colony-stimulating factor accelerates hemopoietic regeneration and enhances survival in a murine model of radiation-induced myelosuppression. Int J Cell Cloning (1990) 0.91
The polysaccharide, PGG-glucan, enhances human myelopoiesis by direct action independent of and additive to early-acting cytokines. Acta Haematol (1999) 0.91
Mechanisms in the in vivo release of lymphokines: relationship of high and low responsiveness to other parameters of the immune response. Infect Immun (1981) 0.90
Bone marrow transplantation in miniature swine. II. Effect of selective genetic differences on marrow engraftment and recipient survival. Transplantation (1988) 0.89
Tumor necrosis factor/cachectin is a less potent inducer of serum amyloid A synthesis than interleukin 1. Lymphokine Res (1987) 0.89
Bone marrow and splenic granulocyte-macrophage colony-stimulating factor and transforming growth factor-beta mRNA levels in irradiated mice. Blood (1995) 0.88
Detection of gap junctions between the progeny of a canine macrophage colony-forming cell in vitro. J Cell Biol (1979) 0.88
Pathophysiological roles of cytokines in development, immunity, and inflammation. FASEB J (1994) 0.87
Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect Immun (1989) 0.87
Ultrastructural localization of tumour necrosis factor-alpha. Histochem J (1994) 0.87
Hematopoietic growth factors and glucocorticoids synergize to mimic the effects of IL-1 on granulocyte differentiation and IL-1 receptor induction on bone marrow cells in vivo. Exp Hematol (1993) 0.87
Acceleration of hematopoietic reconstitution with a synthetic cytokine (SC-55494) after radiation-induced bone marrow aplasia. Blood (1996) 0.86
Recovery from severe hematopoietic suppression using recombinant human granulocyte-macrophage colony-stimulating factor. Exp Hematol (1988) 0.86
Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia. Exp Hematol (1993) 0.85
Cytokines in radioprotection. Comparison of the radioprotective effects of IL-1 to IL-2, GM-CSF and IFN gamma. Lymphokine Res (1986) 0.85
Alterations induced in macrophage and granulocyte-macrophage colony-forming cells by a single injection of mice with Corynebacterium parvum. J Reticuloendothel Soc (1979) 0.85
Combined modality radioprotection: the use of glucan and selenium with WR-2721. Int J Radiat Oncol Biol Phys (1990) 0.85
Mechanisms in the in vivo release of lymphokines. II. Regulation of in vivo release of type II interferon IFN gamma. Cell Immunol (1981) 0.84
CFUs kinetics observed in vivo by bromodeoxyuridine and near-UV light treatment. Exp Hematol (1981) 0.84
Cardiopulmonary effects of granulocyte colony-stimulating factor in a canine model of bacterial sepsis. J Appl Physiol (1985) (1994) 0.84
Bone marrow transplantation in miniature swine. III. Graft-versus-host disease and the effect of T cell depletion of marrow. Transplantation (1988) 0.84
Increased fibrinogen synthesis in mice during the acute phase response: co-operative interaction of interleukin 1, interleukin 6, and interleukin 1 receptor antagonist. Cytokine (1993) 0.84
Advances in radioprotection through the use of combined agent regimens. Int J Radiat Biol (1990) 0.84
Comparative effects of soluble and particulate glucans on survival in irradiated mice. J Biol Response Mod (1986) 0.83
The effect of cyclophosphamide on suppressor cells in guinea pigs. Cell Immunol (1977) 0.83
Improved survival of dogs exposed to fission neutron irradiation and transplanted with DLA identical bone marrow. Bone Marrow Transplant (1987) 0.83
Evaluation of immunologic assays to determine the effects of differential housing on immune reactivity. Brain Behav Immun (1990) 0.83
Endotoxin-induced alterations in canine granulopoiesis: colony-stimulating factor, colony-forming cells in culture, and growth of cells in diffusion chambers. Exp Hematol (1978) 0.83
Soluble polyglycans enhance recovery from cobalt-60--induced hemopoietic injury. J Biol Response Mod (1984) 0.83
Granulocyte colony-stimulating factor and amifostine (Ethyol) synergize to enhance hemopoietic reconstitution and increase survival in irradiated animals. Semin Oncol (1994) 0.82
Effects of pre- and post-irradiation glucan treatment on pluripotent stem cells, granulocyte, macrophage and erythroid progenitor cells, and hemopoietic stromal cells. Experientia (1984) 0.81
Dose-dependent responses of murine pluripotent stem cells and myeloid and erythroid progenitor cells following administration of the immunomodulating agent glucan. Immunopharmacology (1983) 0.81
Mechanisms in the in vivo release of lymphokines. 1. Comparative kinetics in the release of six lymphokines in inbred strains of mice. Cell Immunol (1981) 0.81
Therapeutic trial of lipid X in a canine model of septic shock. J Infect Dis (1993) 0.81
Stimulated hemopoiesis and enhanced survival following glucan treatment in sublethally and lethally irradiated mice. Int J Immunopharmacol (1985) 0.81
An overview on interleukin-1 as a therapeutic agent. Biotherapy (1989) 0.81
A comparative evaluation of particulate and soluble glucan in an endotoxin model. Int J Immunopharmacol (1986) 0.81
Biologic properties of bacterial lipopolysaccharides treated with chromium chloride. Can J Microbiol (1978) 0.80
Rat monocytes in a model of combined injury express the OX8 antigen. J Leukoc Biol (1987) 0.80
Detection of in vitro macrophage colony-forming cells (M-CFC) in mouse bone marrow, spleen, and peripheral blood. J Cell Physiol (1978) 0.80